Dolby Laboratories (DLB)
Official siteINDUSTRIALS • SPECIALTY BUSINESS SERVICES • NYSE
Market Cap: $5.73B
Last updated: Nov 17, 2026 at 4:43 PM ET
Dolby Laboratories (DLB) Statistics
Dolby Laboratories (DLB) has a market cap of $5.73B and an enterprise value of $5.11B. Its trailing P/E of 15.2x is below its 10-year median of 22.2x. It holds $622.88M more cash than debt, 10.87% of its market cap.
Total Valuation
Enterprise value is 10.87% below the market cap, as cash exceeds debt.
| Market Cap | $5.73B |
|---|---|
| Enterprise Value | $5.11B |
| Latest price (Nov 17, 2026) | $58.64 |
Key Dates
The next earnings report is set for Nov 17, 2026, after the close. The last ex-dividend date was Aug 11, 2026.
| Next Earnings Date | Nov 17, 2026, after the close |
|---|---|
| Last Earnings Date | Jul 30, 2026 |
| Last Ex-Dividend Date | Aug 11, 2026 |
| Last Payment Date | Aug 19, 2026 |
| Fiscal Year End | September |
Valuation Ratios
Sales and book value multiples are 3.9x and 2.1x. Its year-end P/E ranged from 15.4x to 29.7x from 2016 to 2025.
| P/E Ratio | 15.2x |
|---|---|
| Forward P/E | 12.7x |
| P/S Ratio | 3.9x |
| Forward P/S | 3.9x |
| P/B Ratio | 2.1x |
| P/TBV Ratio | 3.3x |
| P/FCF Ratio | 15.4x |
| P/OCF Ratio | 14.3x |
| PEG Ratio | 1.8 |
Enterprise Valuation
Counting debt and cash, the company is valued at 11.6x EBITDA and 13.7x free cash flow.
| EV / Earnings | 19.7x |
|---|---|
| EV / Sales | 3.6x |
| EV / EBITDA | 11.6x |
| EV / FCF | 13.7x |
Price Statistics
The stock is down 9.01% over 52 weeks and trades 3.71% below its 50-day average.
| Beta (1Y) | 0.54 |
|---|---|
| 52-Week Change | -9.01% |
| 1-Month Change | -3.96% |
| 3-Month Change | -6.48% |
| 6-Month Change | +10.52% |
| 5-Year Change | -29.84% |
| 10-Year Change | +30.26% |
| Total Return (1Y) | -6.77% |
| Total Return (3Y CAGR) | -8.94% |
| Total Return (5Y CAGR) | -6.89% |
| Return vs SPY (1Y) | -19.73% |
| Max Drawdown (1Y) | -29.74% |
| Max Drawdown (3Y) | -43.53% |
| Sharpe Ratio (1Y) | -0.29 |
| Correlation with SPY (1Y) | 0.25 |
| 50-Day Average | $60.90 |
| 200-Day Average | $59.03 |
| 52-Week Range | $47.98 to $69.11 |
| RSI (14 Days) | 32.8 |
| Average Volume (20 Days) | 900.23K |
The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Current assets cover 3.18x current liabilities, and total debt is 0.00x shareholder equity.
| Current Ratio | 3.18x |
|---|---|
| Quick Ratio | 3.11x |
| Debt / Equity | 0.00x |
| Interest Coverage | -19.24x |
Returns and Efficiency
Return on equity is 9.97% over the last 12 months, against a 5-year average of 9.43%.
| Return on Equity (ROE) | 9.97% |
|---|---|
| Return on Assets (ROA) | 8.19% |
| ROE (5Y Average) | 9.43% |
| ROA (5Y Average) | 7.65% |
| ROIC (5Y Average) | 9.42% |
| Asset Turnover | 0.44x |
| Inventory Turnover | 6.30x |
| Receivables Turnover | 4.85x |
| Cash Conversion Cycle | 102 days |
Taxes
Income tax took 23.08% of pretax income over the last 12 months.
| Income Tax (TTM) | $77.86M |
|---|---|
| Effective Tax Rate | 23.08% |
Scores
DLB has an Altman Z-Score of 8.27, in the safe zone above 2.99, and a Piotroski F-Score of 7 of 9, in the average band of 3 to 7.
Altman Z-ScoreDistress below 1.81Safe above 2.99
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Altman Z-Score | 8.27 |
|---|---|
| Altman Z Zone | Safe |
| Piotroski F-Score | 7 of 9 |
| Piotroski Strength | Average |
Income Statement
Revenue of $1.42B over the last 12 months is up 5.32% from the 12 months before.
| Revenue | $1.42B |
|---|---|
| Revenue Growth (YoY) | +5.32% |
| Gross Profit | $1.23B |
| Operating Income | $303.99M |
| Pretax Income | $337.38M |
| Net Income | $259.52M |
| EBITDA | $425.98M |
| Reported EPS (TTM) | $3.85 |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
Shareholder equity funds 82.02% of the $3.17B in total assets.
| Cash and Equivalents | $622.88M |
|---|---|
| Total Debt | $0 |
| Net Cash | $622.88M |
| Net Cash Per Share | $6.59 |
| Working Capital | $911.39M |
| Shareholder Equity | $2.60B |
| Book Value Per Share | $27.53 |
| Tangible Book Value | $1.69B |
| Tangible Book Per Share | $17.82 |
| Total Assets | $3.17B |
| Total Liabilities | $556.01M |
Balance sheet as of Sep 30, 2026.
Cash Flow
After $39.63M of capital spending, operating cash flow left $359.91M of free cash flow.
| Operating Cash Flow | $399.55M |
|---|---|
| Capital Expenditures | $39.63M |
| Free Cash Flow | $359.91M |
| FCF Per Share | $6.06 |
| Depreciation and Amortization | $105.27M |
| Dividends Paid | $138.54M |
| Share Repurchases | $299.62M |
Trailing 12 months through Sep 30, 2026.
Margins
The operating margin is 21.39%, against a 5-year average of 18.88%.
| Gross Margin | 86.87% |
|---|---|
| Operating Margin | 21.39% |
| Pretax Margin | 23.74% |
| Net Margin | 18.27% |
| EBITDA Margin | 29.98% |
| FCF Margin | 25.33% |
| Gross Margin (5Y Average) | 88.19% |
| Operating Margin (5Y Average) | 18.88% |
| Net Margin (5Y Average) | 17.64% |
Growth
Revenue grew 3.01% a year over 3 years, and EPS fell 7.12% a year.
| Revenue Growth (3Y CAGR) | +3.01% |
|---|---|
| Revenue Growth (5Y CAGR) | +2.09% |
| EPS Growth (3Y CAGR) | -7.12% |
| EPS Growth (5Y CAGR) | -4.92% |
| FCF Growth (3Y CAGR) | +2.24% |
| FCF Growth (5Y CAGR) | -1.76% |
| Operating Income Growth (3Y CAGR) | +12.11% |
| Book Value Per Share Growth (2Y CAGR) | +5.98% |
| Tangible Book Per Share Growth (2Y CAGR) | -1.96% |
Dividends and Yields
DLB pays out 34.08% of earnings as dividends.
| Dividend Per Share (Annual) | $1.44 |
|---|---|
| Dividend Yield | 2.46% |
| Payment Schedule | Quarterly |
| Dividend Growth (3Y CAGR) | +9.79% |
| Dividend Growth (5Y CAGR) | +8.94% |
| Payout Ratio | 34.08% |
| FCF Payout Ratio | 38.49% |
| Earnings Yield | 6.58% |
| FCF Yield | 6.49% |
| Buyback Yield | 5.40% |
| Shareholder Yield | 7.90% |
Peer Position
Against 10 similar companies, DLB has the 7th highest P/E.
P/E RatioPeer median 20.6x
P/S RatioPeer median 1.1x
Revenue Growth (Trailing 4 Quarters, YoY)Peer median +14.35%
Dividend YieldPeer median 0.81%
| P/E Ratio | 15.2x vs 20.6x median |
|---|---|
| P/S Ratio | 3.9x vs 1.1x median |
| Revenue Growth (Trailing 4 Quarters, YoY) | +5.32% vs +14.35% median |
| Dividend Yield | 2.46% vs 0.81% median |
Analyst Forecast
Consensus estimates put revenue growth at 3.26% and EPS growth at 60.14% a year over the next fiscal year.
| Revenue Growth Forecast (1Y CAGR) | +3.26% |
|---|---|
| EPS Growth Forecast (1Y CAGR) | +60.14% |
Price Target
Analyst price targets are part of paid GNG plans. See plans
GNG Valuation
| GNG view | Undervalued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About DLB
What is DLB's market cap?
Dolby Laboratories has a market cap of $5.73B. Its enterprise value, which adds debt and subtracts cash, is $5.11B.
What is DLB's P/E ratio?
Dolby Laboratories has a trailing P/E ratio of 15.2x and a forward P/E of 12.7x.
How many shares of DLB are outstanding?
Dolby Laboratories has 94.57M shares outstanding. The count is down 1.73% from a year earlier.
Does DLB pay a dividend?
Yes. Dolby Laboratories pays $1.44 a share a year, a dividend yield of 2.46%.
How much debt does DLB have?
Dolby Laboratories has $0 of total debt and $622.88M of cash and equivalents, a net cash position of $622.88M.
DLB pages: Overview, Dividends, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors